|
1
|
Nautsch F, Ludwig JM, Xing M, Johnson KM
and Kim HS: Racial disparities and sociodemographic differences in
incidence and survival among pediatric patients in the United
States with primary liver cancer: A surveillance, epidemiology, and
end results (SEER) population study. J Clin Gastroenterol.
52:262–267. 2018.PubMed/NCBI
|
|
2
|
Xu K, Watanabe-Galloway S, Rochling FA,
Zhang J, Farazi PA, Peng H, Wang H and Luo J: Practice, knowledge,
and barriers for screening of hepatocellular carcinoma among
high-risk chinese patients. Ann Glob Health. 83:281–292. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He CB and Lin XJ: Inflammation scores
predict the survival of patients with hepatocellular carcinoma who
were treated with transarterial chemoembolization and recombinant
human type-5 adenovirus H101. PLoS One. 12:e01747692017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsu CS and Kao JH: An update on
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
in Asia. Expert Rev Gastroenterol Hepatol. 11:759–772. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Erstad DJ and Tanabe KK: Hepatocellular
carcinoma: Early-stage management challenges. J Hepatocell
Carcinoma. 4:81–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SJ and Lim HY: Hepatocellular
carcinoma treatment: A comparative review of emerging growth factor
receptor antagonists. Expert Opin Emerg Drugs. 22:191–200. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rabinel P, Dousse D, Muscari F and Suc B:
Management of liver cancer. The Surgeon's point of view. Rep Pract
Oncol Radiother. 22:176–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rai V, Abdo J, Alsuwaidan AN, Agrawal S,
Sharma P and Agrawal DK: Cellular and molecular targets for the
immunotherapy of hepatocellular carcinoma. Mol Cell Biochem.
437:13–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong S, Cheng Q, Huang L, Wang J, Sha M,
Tong Y, Xia L, Han L, Xi Z, Zhang J, et al: Risk stratification
system to predict recurrence of intrahepatic cholangiocarcinoma
after hepatic resection. BMC Cancer. 17:4642017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu Y, Cai F, Zhao J and Liu F: Prognostic
risk factors associated with recurrence and metastasis after
radical resection in patients with hepatolithiasis complicated by
intrahepatic cholangiocarcinoma. Cell Biochem Biophys. 73:455–460.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ni Q, Shen W, Zhang M, Yang C, Cai W, Wu M
and Yang J: Prognostic analysis of radical resection for
intrahepatic cholangiocarcinoma: A retrospective cohort study.
Oncotarget. 8:75627–75637. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maganty K, Levi D, Moon J, Bejarano PA,
Arosemena L, Tzakis A and Martin P: Combined hepatocellular
carcinoma and intrahepatic cholangiocarcinoma: Outcome after liver
transplantation. Dig Dis Sci. 55:3597–3601. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elshamy M, Presser N, Hammad AY, Firl DJ,
Coppa C, Fung J and Aucejo FN: Liver transplantation in patients
with incidental hepatocellular carcinoma/cholangiocarcinoma and
intrahepatic cholangiocarcinoma: A single-center experience.
Hepatobiliary Pancreat Dis Int. 16:264–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chinchilla-Lopez P, Aguilar-Olivos NE,
Garcia-Gomez J, Hernández-Alejandro KK, Chablé-Montero F,
Motola-Kuba D, Patel T and Méndez-Sánchez N: Prevalence, risk
factors, and survival of patients with intrahepatic
cholangiocarcinoma. Ann Hepatol. 16:565–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tarocchi M, Polvani S, Marroncini G and
Galli A: Molecular mechanism of hepatitis B virus-induced
hepatocarcinogenesis. World J Gastroenterol. 20:11630–11640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song W, Wang K, Zhong FP, Fan YW, Peng L
and Zou SB: Clinicopathological and prognostic significance of
platelet-to-lymphocyte ratio in patients with hepatocellular
carcinoma. Oncotarget. 7:81830–81838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu SJ, Ji F, Han M, Chen MG, Wang XP, Ju
WQ, Zhao Q, Wu LW, Ren QQ, Guo ZY, et al: Prognostic value of
combined preoperative fibrinogen and neutrophil-lymphocyte ratio in
patients with hepatocellular carcinoma after liver transplantation.
Oncotarget. 8:4301–4312. 2017.PubMed/NCBI
|
|
19
|
Howell J, Pinato DJ, Ramaswami R, Arizumi
T, Ferrari C, Gibbin A, Burlone ME, Guaschino G, Toniutto P, Black
J, et al: Integration of the cancer-related inflammatory response
as a stratifying biomarker of survival in hepatocellular carcinoma
treated with sorafenib. Oncotarget. 8:36161–36170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jing CY, Fu YP, Shen HJ, Zheng SS, Lin JJ,
Yi Y, Huang JL, Xu X, Zhang J, Zhou J, et al: Albumin to
gamma-glutamyltransferase ratio as a prognostic indicator in
intrahepatic cholangiocarcinoma after curative resection.
Oncotarget. 8:13293–13303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okuno M, Ebata T, Yokoyama Y, Igami T,
Sugawara G, Mizuno T, Yamaguchi J and Nagino M: Evaluation of
inflammation-based prognostic scores in patients undergoing
hepatobiliary resection for perihilar cholangiocarcinoma. J
Gastroenterol. 51:153–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng ZW, Pan W, Hong HJ, Chen JZ and Chen
YL: Modified staging classification for intrahepatic
cholangiocarcinoma based on the sixth and seventh editions of the
AJCC/UICC TNM staging systems. Medicine (Baltimore). 96:e78912017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Jia H, Yu W, Xu Y, Li X, Li Q and
Cai S: Nomograms for predicting prognostic value of inflammatory
biomarkers in colorectal cancer patients after radical resection.
Int J Cancer. 139:220–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi S, Chen Q, Ye L, Yin D, Li X, Dai Z
and He J: Prognostic value of systemic inflammation score in
patients with hepatocellular carcinoma after hepatectomy.
Oncotarget. 8:79366–79375. 2017.PubMed/NCBI
|
|
25
|
Hu D, Lin Y, Liu F, Zeng L, Ouyang X, Wang
K, Zheng X and Huang Q: Elevated preoperative platelet to
lymphocyte ratio indicates poor survival in patients with resected
high-grade serous ovarian carcinoma. Clin Lab. 62:1443–1449. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi L, Qin X, Wang H, Xia Y, Li Y, Chen X,
Shang L, Tai YT, Feng X, Acharya P, et al: Elevated
neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and
decreased platelet-to-lymphocyte ratio are associated with poor
prognosis in multiple myeloma. Oncotarget. 8:18792–18801.
2017.PubMed/NCBI
|
|
27
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen TH, Zhang YC, Tan YT, An X, Xue C,
Deng YF, Yang W, Yuan X and Shi YX: Tumor-infiltrating lymphocytes
predict prognosis of breast cancer patients treated with anti-Her-2
therapy. Oncotarget. 8:5219–5232. 2017.PubMed/NCBI
|
|
29
|
Ji H, Houghton AM, Mariani TJ, Perera S,
Kim CB, Padera R, Tonon G, McNamara K, Marconcini LA, Hezel A, et
al: K-ras activation generates an inflammatory response in lung
tumors. Oncogene. 25:2105–2112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shalapour S and Karin M: Immunity,
inflammation, and cancer: An eternal fight between good and evil. J
Clin Invest. 125:3347–3355. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maeda K, Shibutani M, Otani H, Nagahara H,
Ikeya T, Iseki Y, Tanaka H, Muguruma K and Hirakawa K:
Inflammation-based factors and prognosis in patients with
colorectal cancer. World J Gastrointest Oncol. 7:111–117. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Beltran BE, Aguilar C, Quiñones P, Morales
D, Chavez JC, Sotomayor EM and Castillo JJ: The
neutrophil-to-lymphocyte ratio is an independent prognostic factor
in patients with peripheral T-cell lymphoma, unspecified. Leuk
Lymphoma. 57:58–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng
H, Wang Z and Xu Y: Neutrophil-to-lymphocyte and
platelet-to-lymphocyte ratios predict chemotherapy outcomes and
prognosis in patients with colorectal cancer and synchronous liver
metastasis. World J Surg Oncol. 14:2892016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hayashi H, Takamura H, Ohbatake Y,
Nakanuma S, Tajima H, Fushida S, Onishi I, Tani T, Shimizu K and
Ohta T: Postoperative changes in neutrophil-to-lymphocyte ratio and
platelet count: A simple prognostic predictor for adult-to-adult
living donor liver transplantation. Asian J Surg. 41:341–348. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu X, He L, Han J, Wang L, Li M, Jiang Y,
Wang X and Yang Z: Association of neutrophil-lymphocyte ratio and T
lymphocytes with the pathogenesis and progression of HBV-associated
primary liver cancer. PLoS One. 12:e01706052017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li SH, Wang QX, Yang ZY, Jiang W, Li C,
Sun P, Wei W, Shi M and Guo RP: Prognostic value of the
neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
patients with portal/hepatic vein tumor thrombosis. World J
Gastroenterol. 23:3122–3132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang J, Zhang HY, Li J, Shao XY and Zhang
CX: The elevated NLR PLR and PLT may predict the prognosis of
patients with colorectal cancer: A systematic review and
meta-analysis. Oncotarget. 8:68837–68846. 2017.PubMed/NCBI
|
|
38
|
Song X, Zhu H, Pei Q, Tan F, Li C, Zhou Z,
Zhou Y, Yu N, Li Y and Pei H: Significance of inflammation-based
indices in the prognosis of patients with non-metastatic colorectal
cancer. Oncotarget. 8:45178–45189. 2017.PubMed/NCBI
|
|
39
|
Taussig MD, Irene Koran ME, Mouli SK,
Ahmad A, Geevarghese S, Baker JC, Lipnik AJ, Banovac F and Brown
DB: Neutrophil to lymphocyte ratio predicts disease progression
following intra-arterial therapy of hepatocellular carcinoma. HPB
(Oxford). 19:458–464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu SJ, Lin YX, Ye H, Li FY, Xiong XZ and
Cheng NS: Lymphocyte to monocyte ratio and prognostic nutritional
index predict survival outcomes of hepatitis B virus-associated
hepatocellular carcinoma patients after curative hepatectomy. J
Surg Oncol. 114:202–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song W, Tian C, Wang K, Zhang RJ and Zou
SB: The pretreatment lymphocyte to monocyte ratio predicts clinical
outcome for patients with hepatocellular carcinoma: A
meta-analysis. Sci Rep. 7:466012017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang C, Wang H, Ning Z, Xu L, Zhuang L,
Wang P and Meng Z: Prognostic nutritional index serves as a
predictive marker of survival and associates with systemic
inflammatory response in metastatic intrahepatic
cholangiocarcinoma. Onco Targets Ther. 9:6417–6423. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang BG, Ge RL, Sun LL, Zong M, Wei GT
and Zhang YJ: Clinical parameters predicting survival duration
after hepatectomy for intrahepatic cholangiocarcinoma. Can J
Gastroenterol. 25:603–608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang C, Wang H, Ning Z, Xu L, Zhuang L,
Wang P and Meng Z: Serum liver enzymes serve as prognostic factors
in patients with intrahepatic cholangiocarcinoma. Onco Targets
Ther. 10:1441–1449. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hyder O, Marques H, Pulitano C, Marsh JW,
Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A,
Barroso E, et al: A nomogram to predict long-term survival after
resection for intrahepatic cholangiocarcinoma: An Eastern and
Western experience. JAMA Surg. 149:432–438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Doussot A, Groot-Koerkamp B, Wiggers JK,
Chou J, Gonen M, DeMatteo RP, Allen PJ, Kingham TP, D'Angelica MI
and Jarnagin WR: Outcomes after resection of intrahepatic
cholangiocarcinoma: External validation and comparison of
prognostic models. J Am Coll Surg. 221:452–461. 2015. View Article : Google Scholar : PubMed/NCBI
|
